Home/Filings/4/0000899243-19-008333
4//SEC Filing

Orford Keith 4

Accession 0000899243-19-008333

CIK 0001496671other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 4:05 PM ET

Size

4.7 KB

Accession

0000899243-19-008333

Insider Transaction Report

Form 4
Period: 2019-03-15
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
  • Sale

    Common Stock

    2019-03-15$6.43/sh417$2,68110,832 total
Footnotes (1)
  • [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1
  • filerCIK 0001670740

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:05 PM ET
Size
4.7 KB